News

Sudhir Srivastava, US National Insititutes of Health, National Cancer Institute USA

The Human Proteome Organization has established a HUPO External Initiative (HEDI) committee to foster interaction between the HUPO membership and international thought leaders who are responsible for developing strategy for funding proteomic-centric projects in their respective countries. HEDI will be chaired by Dr. Sudhir Srivastava, Chief, Cancer Biomarkers Research Group, National Cancer Institute, National Institutes of Health along with co-chairs Dr. Rob Moritz, HUPO Vice President and Institute for Systems Biology, Seattle WA USA and Dr. Mike Snyder (HUPO Past President and Stanford University, CA USA). The objectives of this initiative are:

• Identifying emerging scientific opportunities, rising public health challenges, or scientific knowledge gaps that merit further research by international funding agencies, non-profit governmental organizations and foundations, hereafter called Funders.
• Understanding scientific priorities and strategic planning of Funders globally in developing and applying resources (databases, analytic tools, and methodologies) and producing specifications for new resources in support of proteomic research
• If requested, assisting the Funders to address areas of emerging scientific opportunities and public health challenges effectively
• Proactively discussing and providing technical assistance to Funders in the development of proteomic-based initiatives.

The first inaugural meeting of this committee will take place during the HUPO Annual Meeting, September 15-19, 2019 to be held in Adelaide, Australia. Planning is underway to invite thought leaders, funding officials and other policy makers to discuss their ongoing and future proteomic projects in their own countries. The format of the meeting will encourage deep interaction among the participants to learn of each other’s needs and the participatory process that culminates in development of proteomic centric projects.